News | April 10, 2023
Need of the hour is Indian Research, Data and Solution to Indian problems: Dr Jitendra Singh
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Women of all ages will get round-the-clock access to comprehensive treatment
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Asthma patients are more likely to have an asthma attack during winter
The companies will leverage their respective proprietary technology platforms
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Subscribe To Our Newsletter & Stay Updated
